A Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following Chemotherapy and Androgen Pathway Inhibitors
Phase of Trial: Phase II
Latest Information Update: 27 Oct 2017
At a glance
- Drugs Carfilzomib (Primary) ; Aciclovir; Dexamethasone; Paracetamol
- Indications Prostate cancer
- Focus Therapeutic Use
- 23 Oct 2017 Status changed from active, no longer recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 19 May 2017 Planned End Date changed from 1 Apr 2018 to 1 Apr 2019.